Wells Fargo’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $450 | Hold |
|
|||||
|
2024
Q3 | $553 | Buy |
|
|||||
|
2024
Q2 | $12 | Sell |
|
|||||
|
2024
Q1 | $51.2K | Buy |
|
|||||
|
2023
Q4 | $25.4K | Buy |
|
|||||
|
2023
Q3 | $30.4K | Sell |
|
|||||
|
2023
Q2 | $84.5K | Sell |
|
|||||
|
2023
Q1 | $652K | Buy |
|
|||||
|
2022
Q4 | $415 | Sell |
|
|||||
|
2022
Q3 | $30K | Sell |
|
|||||
|
2022
Q2 | $31K | Sell |
|
|||||
|
2022
Q1 | $302K | Sell |
|
|||||
|
2021
Q4 | $424K | Buy |
|
|||||
|
2021
Q3 | $148K | Sell |
|
|||||
|
2021
Q2 | $316K | Sell |
|
|||||
|
2021
Q1 | $1.1M | Sell |
|
|||||
|
2020
Q4 | $2.49M | Sell |
|
|||||
|
2020
Q3 | $2.61M | Sell |
|
|||||
|
2020
Q2 | $3.42M | Buy |
|
|||||
|
2020
Q1 | $1.22M | Buy |
|
|||||
|
2019
Q4 | $1.18M | Buy |
|
|||||
|
2019
Q3 | $571K | Sell |
|
|||||
|
2019
Q2 | $361K | Buy |
|
|||||
|
2019
Q1 | $325K | Buy |
|
|||||
|
2018
Q4 | $426K | Buy |
|
|||||
|
2018
Q3 | $720K | Buy |
|
|||||
|
2018
Q2 | $629K | Buy |
|
|||||
|
2018
Q1 | $483K | Buy |
|
|||||
|
2017
Q4 | $298K | Buy |
|
|||||
|
2017
Q3 | $285K | Buy |
|
|||||
|
2017
Q2 | $213K | Sell |
|
|||||
|
2017
Q1 | $560K | Buy |
|
|||||
|
2016
Q4 | $191K | Buy |
|
|||||
|
2016
Q3 | $129K | Sell |
|
|||||
|
2016
Q2 | $91K | Sell |
|
|||||
|
2016
Q1 | $134K | Sell |
|
|||||
|
2015
Q4 | $1.79M | Buy |
|
|||||
|
2015
Q3 | $115K | Buy |
|
|||||
|
2015
Q2 | $286K | Buy |
|
|||||
|
2015
Q1 | $122K | Buy |
|
|||||
|
2014
Q4 | $24K | Hold |
|
|||||
|
2014
Q3 | $22K | Sell |
|
|||||
|
2014
Q2 | $41K | Buy |
|